Low risk — use of or exposure to this product is not likely to cause adverse health consequences.
Acne Treatment Pads (2% salicylic acid) Recalled by Huijing (Shanghai) Bio-tech Co., Ltd. Due to Subpotent drug: The product active ingredient level not...
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Huijing (Shanghai) Bio-tech Co., Ltd. directly.
Affected Products
Acne Treatment Pads (2% salicylic acid), packaged in a 50-count jar, OTC, Distributed by: Greenbrier International, Inc. 500 Volvo Parkway, Chesapeake, VA 23320, NDC 71537-001-02
Quantity: 75,000 pads
Why Was This Recalled?
Subpotent drug: The product active ingredient level not matching the exact levels indicated on the packaging label.
Where Was This Sold?
This product was distributed to 1 state: VA
About Huijing (Shanghai) Bio-tech Co., Ltd.
Huijing (Shanghai) Bio-tech Co., Ltd. has 1 total recall tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report